Dieter Karl Bartschat, M.D., PH.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 863 Willow Cove Rd, Chapin, SC 29036 Phone: 803-549-8349 |
News Archive
Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US.
Access to health insurance is very limited for immigrants living in the U.S. - both undocumented immigrants and permanent residents. But a new survey has found that many U.S. adults who work on behalf of children think undocumented immigrant children should have access to healthcare equal to that of U.S.-born children.
With numerous book bindings scattered on the floor, the room looked as if there had been a rebellion against literature. But in fact, students were celebrating the new equipment added to Eastern Michigan University's Center for Adaptive Technology and Education (CATE), that currently serves enrolled students, faculty and staff with a disability.
Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisureâ„¢, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society's (AUGS) Annual Meeting.
› Verified 4 days ago